Publications

Copyright after Mio and konektra: German Federal Supreme Court Rules on Copyright Protection of the “USM Haller” Furniture System

par Dr. Gregor Schmid, LL.M. (Cambridge) et Caroline Bunz

Germany as a Hub: Logistical Resilience between Operational Planning and Regulatory Frameworks

par Timo Stellpflug et Dr. Martin Knaup, LL.B.

Arnsberg Local Court follows ECJ line in Brillen Rottler case

par Susan Lipeyko, Lic. en droit (Toulouse I Capitole) et Alexander Schmalenberger, LL.B.

Open Source in Healthcare and Life Sciences – Legal Framework and Compliance Requirements

Open source in healthcare requires robust compliance and security standards.

par Jan Feuerhake, LL.M. (Melbourne) et Gabriel Danyeli, LL.M. (Köln/Istanbul Bilgi)

Le harcèlement sexuel « d'ambiance » reconnu par la Cour de cassation : un tournant pour les enquêtes internes !

par Mounira Freih-Bengabou

Labeling AI-Generated Content – Implementing the Transparency Requirements of the AI Regulation in the Automotive Sector

par Thomas Kahl et Nils von Reith

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

par plusieurs auteurs

Lettre du CGP n ° 37

par Philippe Glaser et Marie Tavant

Hungarian supreme court on legal standing to challenge generic marketing authorisations

Case law – Hungarian Supreme Court (Kúria), precedent-setting judgment of 7 May 2026 – Kfv.37.810/2025/27 – On legal standing to challenge generic marketing authorisations

par Fruzsina Kónya

8 de 9 Publications

Case law – VfGH on the eImpfpass and central vaccination register

The Austrian Constitutional Court rejected challenges to the eImpfpass and central vaccination register on procedural grounds. The decision leaves the register in place, but highlights the role of data protection remedies in digital health infrastructure.

par Christopher Bakier

6 de 9 Publications

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

The new EU Product Liability Directive applies to products placed on the market after 9 December 2026. Three changes call for decisions by life sciences companies now: software and AI as products, an eased burden of proof, and disclosure of internal evidence.

par Bartosz Świdrak

3 de 9 Publications

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

Digital Omnibus Update. More time (up to August 2028) yet confirming that AI-enabled medical devices and IVDs stay subject to the AI Act.

par Irina Rebin

4 de 9 Publications